Compare American Express Co (AXP) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Express Co vs Davita Inc — how do they compare? American Express Co trades at $338.69 (market cap $228.84B), while Davita Inc trades at $183.35 (market cap $11.72B). The key difference: American Express Co is far larger — about 19.5× Davita Inc's market cap, and American Express Co pays a 1.12% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| AXP | DVA | |
|---|---|---|
Market Cap | $228.84B | $11.72B |
Sector | Financials | Health |
52-Week High | $384.82 | $240.96 |
52-Week Low | $292.27 | $103.87 |
Dividend Yield | 1.12% | — |
Enterprise Value | — | $24.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
American Express (AXP) trades at $340.91, down 0.49% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings of $4.53 EPS, beating estimates, and maintains robust fundamentals with 15.07% net income margin and 33.97% ROE. Recent news highlights Amex's focus on premium card member experiences and strategic investments in AI for small businesses.
AXP presents a compelling growth story with consistent revenue expansion and strong profitability, though premium valuation metrics (P/E 20.69, P/B 6.72) warrant caution. Analyst consensus leans bullish with a $369.42 price target, representing 8.4% upside potential. Key risks include competitive pressures in payments and sensitivity to economic cycles affecting consumer spending.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Express Co
American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
